Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 124292
Published online Nov 27, 2026. doi: 10.4240/wjgs.124292
Published online Nov 27, 2026. doi: 10.4240/wjgs.124292
Table 8 Comparison of long-term oncologic outcomes between the two groups, n (%)
| Parameters | Non-eradication group (n = 143) | Eradication group (n = 128) | χ2 | P value |
| 5-year OS rate (%) | 80.42 | 91.41 | 6.618 | 0.010 |
| All-cause death | 28 (19.58) | 11 (8.59) | ||
| 5-year DFS rate (%) | 72.73 | 85.94 | 7.097 | 0.008 |
| Recurrence or metastasis | 39 (27.27) | 18 (14.06) | ||
| Local recurrence | 14 (9.79) | 6 (4.69) | ||
| Regional recurrence | 10 (6.99) | 5 (3.91) | ||
| Distant metastasis | 15 (10.49) | 7 (5.47) | ||
| Metachronous gastric cancer | 11 (7.69) | 2 (1.56) | 5.557 | 0.018 |
| Gastric cancer-specific death | 22 (15.38) | 8 (6.25) | 5.725 | 0.017 |
- Citation: Shi RC, Jin D, Su D, Yang XT, Wang X, Hao JF, Yang ZW. Impact of perioperative Helicobacter pylori eradication therapy on long-term survival after distal gastrectomy for gastric cancer. World J Gastrointest Surg 2026; 18(11): 124292
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124292.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124292